KSHP Lunch & Learn
Secondary Stroke Prevention: Unmet Need and Residual Risk
Sponsored By Bayer
Session Detail: Despite advancements in stroke care, there is a residual risk of secondary stroke development. Stroke recurrence rate in patients with non-cardioembolic ischemic stroke can be >7% in the 3 months following a stroke. Furthermore, the increased risk for subsequent strokes continues beyond the acute, 3-month period, out to 5 years and beyond. This session will be dedicated to the review of secondary stroke prevention and the unmet need in this patient population. It will be an interactive session, and active conversation/inquiries in the realm of secondary stroke prevention are encouraged throughout.
Megan Kunka Fritz, PharmD, BCPS
Senior Medical Science Liaison – Cardiovascular
Megan Kunka Fritz, PharmD, BCPS is a Senior Medical Science Liaison (MSL) with Bayer Medical Affairs who covers the Stroke/Thrombosis therapeutic area. Prior to joining Bayer, she was a Medical Science Liaison with Johnson&Johnson Innovative Medicine within the Neuroscience therapeutic area. Before her transition to industry, she was an Internal Medicine Clinical Pharmacist at the University of Kentucky HealthCare for nearly 10 years and served as Residency Program Director for the PGY2 Internal Medicine Pharmacy Residency Program for 7 years. She is originally from Ohio, where she earned her Doctor of Pharmacy degree and completed her PGY1 Pharmacy Practice Residency at the University of Cincinnati Medical Center followed by a PGY2 Internal Medicine Pharmacy Residency at the University of Kentucky HealthCare.
KSHP members receive complimentary registration.
Zoom link to join the meeting is provided in the event confirmation message.
Sponsored by:
Recent Comments